Shares of hVIVO plc (LON:HVO – Get Free Report) passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 26.82 ($0.33) and traded as low as GBX 20 ($0.25). hVIVO shares last traded at GBX 20.50 ($0.25), with a volume of 933,350 shares traded.
hVIVO Price Performance
The company has a market capitalization of £129.95 million, a PE ratio of 636.67 and a beta of 0.97. The business has a 50-day moving average of GBX 23.39 and a 200 day moving average of GBX 26.71. The company has a debt-to-equity ratio of 33.86, a current ratio of 1.61 and a quick ratio of 1.16.
hVIVO Company Profile
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
See Also
- Five stocks we like better than hVIVO
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Insiders Are Selling, But These 3 Stocks Are Must-Buys
- What does consumer price index measure?
- Rivian Defies Doubters: Delivery Triumph Fuels Stock Surge
- What is the Nasdaq? Complete Overview with History
- Hindenburg Short Report Slams Carvana Over Alleged ‘Grift’
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
